Glauce B. De Barros Viana-Viana
Fortaleza, CE, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vitamin D3 actions on astrocyte cells: A target for therapeutic strategy in Parkinson's disease?
Journal: Neuroscience letters
Published: September 24, 2022
Vitamin D (VD3) Intensifies the Effects of Exercise and Prevents Alterations of Behavior, Brain Oxidative Stress, and Neuroinflammation, in Hemiparkinsonian Rats.
Journal: Neurochemical research
Published: March 09, 2022
1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
Journal: Neurochemical research
Published: February 19, 2022
Effects of vitamin D (VD3) supplementation on the brain mitochondrial function of male rats, in the 6-OHDA-induced model of Parkinson's disease.
Journal: Neurochemistry international
Published: September 19, 2021
L-linalool exerts a neuroprotective action on hemiparkinsonian rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 10, 2019
Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
Journal: Journal of neuroinflammation
Published: March 26, 2018
Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.
Journal: Neurochemical research
Published: March 19, 2017
Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Journal: Behavioural brain research
Published: November 27, 2013
Anti-inflammatory effects and possible mechanism of action of lupeol acetate isolated from Himatanthus drasticus (Mart.) Plumel.
Journal: Journal of inflammation (London, England)
Published: May 28, 2010
Showing 1-9 of 9
Last Updated: 09/26/2026